clinical trial · NCT04754217
Valved Graft PMCF Study
Abbott Medical Devices·—·recruiting·n = 260
Aortic Valve DiseaseAscending Aorta AbnormalityAortic DissectionVAVGJCAVGJ
brief summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
started
Jul 13, 2021
primary completion
Jul 1, 2029
completion
Sep 1, 2029
last updated
Apr 13, 2026
official title
Valved Graft Post-Market Clinical Follow-up Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol